Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 11 Carcinoma, Renal Cell 4 Liver Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Endometrial Neoplasms 2 Biliary Tract Neoplasms 2 von Hippel-Lindau Disease 1 Vulvar Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer 1 Hematologic Neoplasms 1 GIST 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Malignancies 1

Interventions

Nivolumab 2 Etoposide 2 Cisplatin 2 repotrectinib 1 gallium Ga 68 dotatate 1 cabozantinib 1 belinostat 1 atezolizumab 1 Temozolomide 1 Radiosurgery 1 Radionuclide Imaging 1 Positron-Emission Tomography 1 Positron Emission Tomography Computed Tomography 1 Ipilimumab 1 DLL3 protein, human 1 Carboplatin 1 Capecitabine 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡